Characterization of an antigen from Leishmania amazonensis amastigotes able to elicit protective responses in a murine model

Infection and Immunity

Volumn 65, Issue 6, 1997, Pages 2052-2059

  Beyrodt, Carolina Guilherme Prestes ^a   Pinto, Aguinaldo Roberto ^a   Freymüller, Edna ^a   Barbiéri, Clara Lúcia ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE PROTEINASE;

AMASTIGOTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN FUNCTION; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; IMMUNE RESPONSE; LEISHMANIA; LEISHMANIASIS; LYMPHOCYTE CULTURE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PROTEIN ANALYSIS; T LYMPHOCYTE ACTIVATION;

EID: 0030915007     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.6.2052-2059.1997     Document Type: Article

References (57)

1. Aboud-Zeid, C., J. Steele, and G. A. W. Rook. 1987. A simple new method for using antigens separated by polyacrylamide gel electrophoresis to stimulate lymphocytes in vitro after converting bands cut from Western blots into antigen-bearing particles. J. Immunol. Methods 98:5-10.
2. Alfieri, S. C., E. Shaw, V. Zilberfarb, and M. Rabinovitch. 1989. Leishmania amazonensis: involvement of cysteine proteinascs in the killing of isolated amastigotes by 1-leucine methyl ester, Exp. Parasitol. 68:423-431.
3. Barbiéri, C. L., S. Giorgio, A. J. C. Merjan, and E. N. Figueiredo. 1993. Glycosphingolipid antigens of Leishmania amazonensis amastigotes identified by use of a monoclonal antibody. Infect. Immun. 61:2131-2137.
4. Barral, A., E. A. Petersen, D. L. Sacks, and F. A. Neva. 1983. Late metastatic leishmaniasis in the mouse. A model for mucocutaneous disease. Am. J. Trop. Med. Hyg. 32:277-285.
5. Barral-Neto, M., S. A. Cardoso, and A. Barral. 1987. Different patterns of disease in two inbred mouse strains infected with a clone of Leishmania mexicana amazonensis. Acta Trop. 44:5-11.
6. Boom, W. H., L. Leibster, A. K. Abbas, and R. G. Titus. 1990. Patterns of cytokine secretion in murine leishmaniasis: correlation with disease progression or resolution. Infect. Immun. 58:3863-3870.
7. Champsi, J., and D. McMahon-Pratt. 1988. Membrane glycoprotein M-2 protects against Leishmania amazonensis infection. Infect. Immun. 56:3272-3279.
8. Chang, K. P., G. Chaudhuri, and D. Fong. 1990. Molecular determinants of Leishmania virulence. Annu. Rev. Microbiol. 44:499-529.
9. Childs, G. E., L. K. Lightner, L. Mckinney, M. G. Groves, E. E. Price, and L. D. Hendricks. 1984. Inbred mice as model hosts for cutaneous leishman iasis. I. Resistance and susceptibility to infection with Leishmania braziliensis, L. mexicana and L. aethiopica. Ann. Trop. Med. Parasitol. 78:25-34.
10. Colomer-Gould, V., L. G. Quintao, J. Keithly, and N. Nogueira. 1985. A common major surface antigen on amastigotes and promastigotes of Leishmania species. J. Exp. Med. 152:902-916.
11. Coombs, G. H. 1982. Proteinases of Leishmania mexicana and other flagellate protozoa. Parasitology 84:149-155.
12. Duboise, S. M., M. A. Vannier-Santos, D. Costa-Pinto, L. Rivas, A. A. Pan, Y. Traub-Cseko, W. Souza, and D. McMahon-Pratt. 1994. The biosynthesis, processing, and immunolocalization of Leishmania pifanoi amastigote cysteine proteinases. Mol. Biochem. Parasitol. 68:119-132.
13. Evans, T. G., S. S. Reed, and J. B. Hibbs, Jr. 1996. Nitric oxide production in murine leishmaniasis: correlation of progressive infection with increasing systemic synthesis of nitric oxide. Am. J. Trop. Med. Hyg. 54:486-489.
14. Fraker, P. J., and J. C. Speck. 1978. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetra-chloro-3a,6a-diphenylgly- couril. Biochem. Biophys. Res. Commun. 80:849-857.
15. Gillis, S., M. M. Ferm, W. Ou, and K. A. Smith. 1978. T cell growth factor: parameters of production and a quantitative microassay for activity. J. Immunol. 120:2027-2032.
16. Giorgio, S., and G. M. de A. Lima Collet. 1986. Cutaneous leishmaniasis: course of the infection, histopathology and cell mediated immunity in three strains of mice, Mem. Inst. Oswaldo Cruz Suppl. 81:121. (Abstract.)
17. Giorgio, S., and D. M. Haig. 1990. Identification of T-cell reactive antigens in Nippostrongylus braziliensis using a cell immunoblotting technique. Braz. J. Med. Biol. Res. 23:573-576.
18. Giorgio, S., M. G. Jasiulionis, A. H. Straus, H. K. Takahashi, and C. L. Barbieri. 1992. Inhibition of mouse lymphocyte proliferative response by glycosphingolipids from Leishmania (L) amazonensis. Exp. Parasitol. 75:119-125.
19. Grimaldi, G., P. L. Moriearty, and R. Hoff. 1980. Leishmania mexicana: immunology and histopathology in C3H mice. Exp. Parasitol. 50:45-56.
20. Handman, E., and G. F. Mitchell. 1985. Immunization with Leishmania receptor for macrophages protects mice against cutaneous leishmaniasis. Proc. Natl. Acad. Sci. USA 82:5910-5914.
21. Heinzel, F. P., M. D. Sadick, B. J. Holaday, R. L. Coffman, and R. M. Locksley. 1989. Reciprocal expression of IFN-γ or IL-4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J. Exp. Mod. 169:59-72.
22. + lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc. Natl. Acad. Sci. USA 88:7011-7015.
23. Hill, J. O., R. J. Northand, and F. M. Collins. 1983. Advantages of measuring changes in the number of viable parasites in murine models of experimental cutaneous leishmaniasis. Infect. Immun. 39:1087-1094.
24. Jaffe, C. L., N. Rachamim, and R. Sarfstein. 1990. Characterization of two proteins from Leishmania donovani and their use for vaccination against visceral leishmaniasis. J. Immunol. 144:699-706.
25. Kaye, P. M., A. J. Curry, and J. M. Blackwell. 1991. Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis. J. Immunol. 146:2763-2770.
26. Kessler, S. W. 1975. Rapid isolation of antigens from cells with a staphylococcal protein-A antibody absorbent: parameters of the interaction of antibody-antigen complexes with protein A. J. Immunol. 115:1617-1624.
27. Köhler, G., and C. Milstein. 1975. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature (London) 256:495-197.
28. Lainson, R., and J. J. Shaw. 1987. Evolution, classification and geographical distribution, p. 1-120. In W. Peters and R. Killick-Kendrick (ed.), The leishmaniasis in biology and medicine. Academic Press Inc., London, United Kingdom.
29. Leal, L., D. Moss, R. Kuhn, W. Muller, and F. Y. Liew. 1993. Interleukin-4 transgenic mice of resistant background are susceptible to Leishmania major infection. Eur. J. Immunol. 23:566-569.
30. Liew, F. Y., and J. S. Dhaliwal. 1987. Distinctive cellular immunity in genetically susceptible BALB/c mice from Leishmania major infection or after subcutaneous immunization with killed parasites. J. Immunol. 138:4450- 4456.
31. Locksley, K. M., F. B. Heinzel, M. D. Sadick, B. J. Holaday, and K. D. Gardner. 1987. Murine cutaneous leishmaniasis: susceptibility correlates with differential expansion of helper T cell subsets. Ann. Inst. Pasteur (Immunology) 138:744-749.
32. McElrath, M. J., G. Kaplan, A. Nusrat, and Z. A. Conn. 1987. Cutaneous leishmaniasis. The detect in T cell influx in BALB/c mice. J. Exp. Med. 165:546-559.
33. Medina-Acosta, E., R. E. Karess, H. Schwartz, and D. G. Russell. 1989. The surface protease (gp63) of Leishmania is expressed hut differentially processed and localized in the amastigote stage. Mol. Biochem. Parasitol. 37: 263-274.
34. Mitchell, G. F., J. M. Curtis, K. G. Scollay, and E. Handman. 1981. Resistance and abrogation of resistance to cutaneous leishmaniasis in reconstituted BALB/c nude mice. Aust. J. Exp. Biol. Med. Sci. 59:539-554.
35. Monjour, L., B. Vouldoukis, B. W. Ogunkolade, C. Hetzel, M. Ichen, and D. Frommel. 1988. Vaccination and treatment trials against murine leishmaniasis with semi-purified Leishmania antigens. Trans. R. Soc. Trop. Med. Hyg. 82:412-415.
36. Nabors, G. S., and J. P. Farrell. 1994. Site-specific immunity to Leishmania major in SWR mice: the site of infection influences susceptibility and expression of the antileishmanial immune response. Infect. Immun. 62:3655-3662.
37. North, M. J., and G. H. Coombs. 1981. Proteinases of Leishmania mexicana amastigotes and promastigotes: analysis by gel electrophoresis. Mol. Biochem. Parasitol. 3:293-300.
38. Pestel, J., J. Defoort, M. Grass-Masse, D. Afchain, A. Capron, and A. Tartar Ouassi. 1992. Polyclonal cell activity of a repeated peptide derived from the sequence of an 85-kilodalton surface protein of Trypanosoma cntzi trypomastigote. Infect. Immun. 60:715-719.
39. Preston, P. M., R. L. Carter, E. Leuchars, A. S. J. Davies, and D. C. Dumonde. 1972. Experimental cutaneous leishmaniasis. Effects of thymectomy on the course of infection of CBA mice with Leishmania tropica. Clin. Exp. Immunol. 10:337-357.
40. Pupkis, M. F., and G. H. Coombs. 1984. Purification and characterization of proteolytic enzymes of Leishmania mexicana mexicana amastigotes and promastigotes. J. Gen. Microbiol. 130:2375-2383.
41. Pupkis, M. F., L. Tetley, and G. H. Coombs. 1986. Leishmania mexicana: amastigote hydrolases in unusual lysosomes. Exp. Parasitol. 62:29-39.
42. Rachamim, N., and C. L. Jaffe. 1993. Pure protein from Leishmania donovani protects mice against both cutaneous and visceral leishmaniasis. J. Immunol. 150:2322-2331.
43. Robertson, C. D., and G. H. Coombs. 1990. Characterization of three groups of cysteine proteinases in the amastigotes of Leishmania mexicana mexicana. Mol. Biochem. Parasitol. 42:269-276.
44. Russell, D. G., and J. Alexander. 1988. Effective immunization against cutaneous leishmaniasis with defined membrane antigens reconstituted into liposomes. J. Immunol. 140:1274-1279.
45. Scott, P. 1990. The role of Th1 and Th2 cells in experimental cutaneous leishmaniasis. Exp. Parasitol. 68:369-372.
46. + T-cell subsets in the regulation of parasitic immunity and disease. Immunol. Rev. 112:161-182.
47. Scott, P., E. Pearce, P. Natovitz, and A. Sher. 1987. Vaccination against cutaneous leishmaniasis in a murine model. II. Immunologic properties of protective and nonprotective subtractions of soluble promastigote extract. J. Immunol. 139:3118-3125.
48. Scott, P., P. Casper, and A. Sher. 1990. Protection against Leishmania major in BALB/c mice by adoptive transfer of a T cell clone recognizing a low molecular weight antigen released by promastigotes. J. Immunol. 144:1075-1079.
49. Soong, L., S. M. Duboise, P. Kima, and D. McMahon-Pratt. 1995. Leishmania pifanoi amastigote antigens protect mice against cutaneous leishmaniasis. Infect. Immun. 63:3559-3566.
50. St. Groth, S. F., and D. Scheldegger. 1980. Production of monoclonal antibodies: strategy and tactics. J. Immunol. Methods 35:1-21.
51. Straus, A. H., S. B. Levery, M. G. Jasiulionis, M. E. K. Salyan, S. J. Steele, L. R. Travassos, S. Hakomori, and H. K. Takahashi. 1993. Stage-specific glycosphingolipids from amastigote forms of Leishmania (L). amazonensis. Immunogenicity and role in parasite binding and invasion of macrophages. J. Biol. Chem. 268:13723-13730.
52. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76:4350-4354.
53. Traub-Cseko, Y. M., M. Dubolse, L. K. Boukai, and D. McMahon-Pratt. 1993. Identification of two distinct cysteine proieinase genes of Leishmania pifanoi axenic amastigotes using the polymerase chain reaction. Mol. Biochem. Parasitol. 57:101-116.
54. Turco, S. J., and D. L. Sacks. 1991. Expression of a stage-specific lipophosphoglycan in Leishmania major amastigotes, Mol. Biochem. Parasitol. 45:91-100.
55. Wilson, M. E., B. M. Young, K. P. Andersen, J. V. Weinstock, A. Metwali, K. M. Ali, and J. E. Donelson. 1995. A recombinant Leishmania chagasi antigen that stimulates cellular immune responses in infected mice. Infect. Immun. 63:2062-2069.
56. Wolfram, M., T. Ilg, J. C. Mottram, and P. Overath. 1995. Antigen presentation by Leishmania mexicana-infected macrophages: activation of helper T cells specific for amastigote cysteine proteinases requires intracellular killing of the parasites, Eur. J. Immunol. 25:1094-1100.
57. Woodward, M. P., W. W. Young, and R. A. Bloodgood. 1985. Detection of monoclonal antibodies specific for carbohydrate epitopes using periodate oxidation. J. Immunol. Methods 78:143-153.